Financhill
Back

Vertex Pharmaceuticals Quote, Financials, Valuation and Earnings

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!
Buy
62

VRTX
Vertex Pharmaceuticals

Last Price:
500.00
Seasonality Move:
6.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Vertex Pharmaceuticals Price Quote

$500.00
+0.12 (+5.64%)
(Updated: November 6, 2024 at 4:12 AM ET)

Vertex Pharmaceuticals Key Stats

Buy
62
Vertex Pharmaceuticals (VRTX) is a Buy

Day range:
$474.00 - $503.21
52-week range:
$341.90 - $510.64
Dividend yield:
0%
P/E ratio:
35.99
P/S ratio:
12.24
P/B ratio:
8.24%

Volume:
1.7M
Avg. volume:
1M
1-year change:
32.88%
Market cap:
$128.8B
Revenue:
$9.9B
EPS:
$-1.99

How Much Does Vertex Pharmaceuticals Make?

Is Vertex Pharmaceuticals Growing As A Company?

Vertex Pharmaceuticals Stock Price Performance

What Is Vertex Pharmaceuticals 52-Week High & Low?

Vertex Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Vertex Pharmaceuticals?

Is Vertex Pharmaceuticals Cash Flow Positive?

  • What Is VRTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$944M
  • What Is Vertex Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1B
  • What Is Vertex Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$3.6B

Vertex Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRTX return on invested capital is -2.89%
  • What Is Vertex Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -2.17%
  • What Is VRTX Return On Equity?
    ROE is a measure of profitability and is -2.89%

Vertex Pharmaceuticals Earnings Date & Stock Price

Vertex Pharmaceuticals Competitors

Vertex Pharmaceuticals Dividend Yield

Vertex Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 1.01% 5.96%
Revenue: 11.61% 3.03%

Analyst Recommendations

Buy Recommendations: 16
Hold Recommendations: 11
Sell Recommendations: 2
Price Target: 511.90
Upside from Last Price: 2.4%

Major Shareholders

  • How many VRTX shares are owned by institutional investors?
    425.9M VRTX shares are owned by institutional investors
  • How many VRTX shares are owned by insiders?
    2.4M VRTX shares are owned by insiders